MYGN

E561081

MYGN is the stock ticker symbol for Myriad Genetics, a molecular diagnostic company specializing in genetic testing for cancer risk and other hereditary conditions.

All labels observed (1)

Label Occurrences
MYGN canonical 2

How this entity was disambiguated

Statements (31)

Predicate Object
instanceOf molecular diagnostics company
public company
stock ticker symbol
aimsTo assess disease risk
guide treatment decisions
analyzes DNA
genetic variants
businessModel commercial genetic testing services
country United States
exchange NASDAQ
focusesOn personalized medicine
precision medicine
foundedAs Myriad Genetics
hasTickerSymbol MYGN
headquartersLocation Salt Lake City, Utah, United States
linked to: Salt Lake City
industry biotechnology
molecular diagnostics
listedOn NASDAQ
offers BRCA gene testing
hereditary breast cancer risk tests
hereditary ovarian cancer risk tests
multigene panel tests
providesServicesTo healthcare providers
patients
represents Myriad Genetics, Inc.
linked to: Myriad Genetics
sector healthcare
securityType common stock
specializesIn cancer risk assessment
genetic testing
hereditary cancer testing
hereditary condition testing

How these facts were elicited

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

Myriad Genetics, Inc. hasTickerSymbol MYGN
subject linked to: MYGN